Cargando…
A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma
PURPOSE: Effective biomarkers and models are needed to improve the prognostic prospects of clear cell renal cell carcinoma (ccRCC). The purpose of this work was to identify DNA methylation biomarkers and to evaluate the utility of DNA methylation analysis for ccRCC prognosis. MATERIALS AND METHODS:...
Autores principales: | Shi, Shanping, Ye, Shazhou, Wu, Xiaoyue, Xu, Mingjun, Zhuo, Renjie, Liao, Qi, Xi, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813151/ https://www.ncbi.nlm.nih.gov/pubmed/31637882 http://dx.doi.org/10.3349/ymj.2019.60.11.1013 |
Ejemplares similares
-
Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients
por: Shi, Shanping, et al.
Publicado: (2020) -
Cytoglobin promotes sensitivity to ferroptosis by regulating p53‐YAP1 axis in colon cancer cells
por: Ye, Shazhou, et al.
Publicado: (2021) -
Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma
por: Yao, Zhi-Yong, et al.
Publicado: (2021) -
LncRNAs GACAT3 and LINC00152 regulate each other through miR‐103 and are associated with clinicopathological characteristics in colorectal cancer
por: Ye, Shazhou, et al.
Publicado: (2020) -
A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
por: Chen, Zhuo, et al.
Publicado: (2022)